Literature DB >> 21221892

A highly effective antiparkinsonian drug of a new structural type.

T G Tolstikova1, A V Pavlova, Ye A Morozova, O V Ardashov, I V Il'ina, K P Volcho, N F Salakhutdinov, G A Tolstikov.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21221892     DOI： 10.1134/S0012496610060074

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  3 in total

Review 1.  Levodopa in the treatment of Parkinson's disease: current controversies.

Authors:  C Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; Ubaldo Bonuccelli; U Bonucelli; Philip Damier; Justo De Yebenes; Oscar Gershanik; Mark Guttman; F Grandas; Mark Hallett; Ole Hornykiewicz; Peter Jenner; R Katzenschlager; William J Langston; Peter LeWitt; Eldad Melamed; M A Mena; P P Michel; Catherine Mytilineou; Jose A Obeso; Werner Poewe; Niall Quinn; R Raisman-Vozari; Ali H Rajput; Olivier Rascol; Christina Sampaio; Fabrizio Stocchi
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  (4S,5R,6R)-para-mentha-1,8-dien-5,6-diol is a new highly effective anticonvulsant agent.

Authors:  T G Tolstikova; A V Pavlova; M P Dolgikh; I V Il'ina; O V Ardashov; K P Volcho; N F Salakhutdinov; G A Tolstikov
Journal:  Dokl Biol Sci       Date:  2009 Nov-Dec

3.  Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  R A Behmand; S I Harik
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.